SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway
- PMID: 30907073
- PMCID: PMC6488116
- DOI: 10.1002/cam4.2056
SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway
Abstract
Radiotherapy is the mainstay and primary curative treatment modality in nasopharyngeal carcinoma (NPC), whose efficacy is limited by the development of intrinsic and acquired radioresistance. Thus, deciphering new molecular targets and pathways is essential for enhancing the radiosensitivity of NPC. SALL4 is a vital factor in the development and prognosis of various cancers, but its role in radioresistance remains elusive. This study aimed to explore the association of SALL4 expression with radioresistance of NPC. It was revealed that SALL4 expression was closely correlated with advanced T classification of NPC patients. Inhibition of SALL4 reduced proliferation and sensitized cells to radiation both in vitro and in vivo. Furthermore, SALL4 silencing increased radiation-induced DNA damage, apoptosis, and G2/M arrest in CNE2 and CNE2R cells. Moreover, knockdown of SALL4 impaired the expression of p-ATM, p-Chk2, p-p53, and anti-apoptosis protein Bcl-2, while pro-apoptosis protein was upregulated. These findings indicate that SALL4 could induce radioresistance via ATM/Chk2/p53 pathway and its downstream proteins related to apoptosis. Targeting SALL4 might be a promising approach for the development of novel radiosensitizing therapeutic agents for radioresistant NPC patients.
Keywords: SALL4; apoptosis; cell cycle; nasopharyngeal carcinoma; radioresistance.
© 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Long noncoding RNA LINC00173 induces radioresistance in nasopharyngeal carcinoma via inhibiting CHK2/P53 pathway.Cancer Gene Ther. 2023 Sep;30(9):1249-1259. doi: 10.1038/s41417-023-00634-x. Epub 2023 May 31. Cancer Gene Ther. 2023. PMID: 37258811
-
CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma.Biomed Pharmacother. 2020 Mar;123:109748. doi: 10.1016/j.biopha.2019.109748. Epub 2019 Dec 20. Biomed Pharmacother. 2020. PMID: 31869663
-
In Vivo and In Vitro Effects of ATM/ATR Signaling Pathway on Proliferation, Apoptosis, and Radiosensitivity of Nasopharyngeal Carcinoma Cells.Cancer Biother Radiopharm. 2017 Aug;32(6):193-203. doi: 10.1089/cbr.2017.2212. Cancer Biother Radiopharm. 2017. PMID: 28820634
-
Epigenetic disruption of cell signaling in nasopharyngeal carcinoma.Chin J Cancer. 2011 Apr;30(4):231-9. doi: 10.5732/cjc.011.10080. Chin J Cancer. 2011. PMID: 21439244 Free PMC article. Review.
-
MicroRNAs involved in chemo- and radioresistance of high-grade gliomas.Tumour Biol. 2013 Aug;34(4):1969-78. doi: 10.1007/s13277-013-0772-5. Epub 2013 Apr 9. Tumour Biol. 2013. PMID: 23568705 Review.
Cited by
-
Silencing AREG Enhances Sensitivity to Irradiation by Suppressing the PI3K/AKT Signaling Pathway in Colorectal Cancer Cells.Biologics. 2024 Sep 28;18:273-284. doi: 10.2147/BTT.S480361. eCollection 2024. Biologics. 2024. PMID: 39359866 Free PMC article.
-
SALL4 promotes cancer stem-like cell phenotype and radioresistance in oral squamous cell carcinomas via methyltransferase-like 3-mediated m6A modification.Cell Death Dis. 2024 Feb 14;15(2):139. doi: 10.1038/s41419-024-06533-9. Cell Death Dis. 2024. PMID: 38355684 Free PMC article.
-
Enhancing nasopharyngeal carcinoma cell radiosensitivity by suppressing AKT/mTOR via CENP-N knockdown.J Transl Med. 2023 Nov 8;21(1):792. doi: 10.1186/s12967-023-04654-x. J Transl Med. 2023. PMID: 37940975 Free PMC article.
-
The new advance of SALL4 in cancer: Function, regulation, and implication.J Clin Lab Anal. 2023 May;37(9-10):e24927. doi: 10.1002/jcla.24927. Epub 2023 Jun 20. J Clin Lab Anal. 2023. PMID: 37337914 Free PMC article. Review.
-
Long noncoding RNA LINC00173 induces radioresistance in nasopharyngeal carcinoma via inhibiting CHK2/P53 pathway.Cancer Gene Ther. 2023 Sep;30(9):1249-1259. doi: 10.1038/s41417-023-00634-x. Epub 2023 May 31. Cancer Gene Ther. 2023. PMID: 37258811
References
-
- Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115‐132. - PubMed
-
- Fu ZT, Guo XL, Zhang SW, et al. Incidence and mortality of nasopharyngeal carcinoma in China, 2014. Chinese journal of oncology. 2018;40:566‐571. - PubMed
-
- Lee AW, Poon YF, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976‐1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys. 1992;23(2):261‐270. - PubMed
-
- Sweetman D, Munsterberg A. The vertebrate spalt genes in development and disease. Dev Biol. 2006;293(2):285‐293. - PubMed
-
- Masuda S, Suzuki K, Izpisua Belmonte JC. Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med. 2013;369(12):1171. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous